{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:12:46Z","timestamp":1740107566232,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T00:00:00Z","timestamp":1650067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T00:00:00Z","timestamp":1650067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s00592-022-01890-3","type":"journal-article","created":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T08:02:55Z","timestamp":1650096175000},"page":"929-937","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The effect of additional acarbose on metformin-associated artificially high 18F-Fluorodeoxyglucose uptake in positron emission tomography\/computed tomography"],"prefix":"10.1007","volume":"59","author":[{"given":"Emre","family":"Urhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emre","family":"Temizer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuleyha","family":"Karaca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ummuhan","family":"Abdulrezzak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Canan Sehit","family":"Kara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aysa","family":"Hacioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2024-7433","authenticated-orcid":false,"given":"Kursad","family":"Unluhizarci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,16]]},"reference":[{"key":"1890_CR1","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.diabres","volume":"131","author":"JP Koffert","year":"2017","unstructured":"Koffert JP, Mikkola K, Virtanen KA et al (2017) Metformin treatment significantly enhances intestinal glucose uptake in patients with type 2 diabetes: Results from a randomized clinical trial. Diabetes Res Clin Pract 131:208\u2013216. https:\/\/doi.org\/10.1016\/j.diabres","journal-title":"Diabetes Res Clin Pract"},{"key":"1890_CR2","doi-asserted-by":"publisher","first-page":"482","DOI":"10.5603\/EP.2017.0050","volume":"68","author":"MP Wrobel","year":"2017","unstructured":"Wrobel MP, Marek B, Kajdaniuk D et al (2017) Metformin- a new old drug. Endokrynol Pol 68:482\u2013496. https:\/\/doi.org\/10.5603\/EP.2017.0050","journal-title":"Endokrynol Pol"},{"key":"1890_CR3","doi-asserted-by":"publisher","first-page":"6156","DOI":"10.1038\/s41598-019-42531-0","volume":"9","author":"O Horakova","year":"2019","unstructured":"Horakova O, Kroupova P, Bartova K et al (2019) Metformin acutely lowers blood glucose levels by inhibition of intestinal glucose transport. Sci Rep 9:6156. https:\/\/doi.org\/10.1038\/s41598-019-42531-0","journal-title":"Sci Rep"},{"key":"1890_CR4","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.2214\/AJR.10.4663","volume":"195","author":"JR Oh","year":"2010","unstructured":"Oh JR, Song HC, Chong A et al (2010) Impact of medication discontinuation on increased intestinal FDG accumulation in diabetic patients treated with metformin. AJR Am J Roentgenol 195:1404\u20131410. https:\/\/doi.org\/10.2214\/AJR.10.4663","journal-title":"AJR Am J Roentgenol"},{"key":"1890_CR5","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.2214\/AJR.10.4663","volume":"20","author":"DW Steenkamp","year":"2014","unstructured":"Steenkamp DW, McDonnell ME, Meibom S (2014) Metformin may be associated with false-negative cancer detection in the gastrointestinal tract on PET\/CT. Endocr Pract 20:1079\u20131083. https:\/\/doi.org\/10.2214\/AJR.10.4663","journal-title":"Endocr Pract"},{"key":"1890_CR6","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/jdi.12864","volume":"9","author":"T Minamii","year":"2018","unstructured":"Minamii T, Nogami M, Ogawa W (2018) Mechanisms of metformin action: \u0131n and out of the gut. J Diabetes Investig 9:701\u2013703. https:\/\/doi.org\/10.1111\/jdi.12864","journal-title":"J Diabetes Investig"},{"key":"1890_CR7","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1097\/MNM.0000000000000728","volume":"38","author":"M Morris","year":"2017","unstructured":"Morris M, Saboury B, Chen W et al (2017) Finding the sweet spot for metformin in 18F-FDG-PET. Nucl Med Commun 38:875\u2013880. https:\/\/doi.org\/10.1097\/MNM.0000000000000728","journal-title":"Nucl Med Commun"},{"key":"1890_CR8","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.2337\/db09-0058","volume":"58","author":"AV Matveyenko","year":"2009","unstructured":"Matveyenko AV, Dry S, Cox HI et al (2009) Beneficial endocrine but adverse exocrine effects of sitagliptin in the human islet amyloid polypeptide transgenic rat model of type 2 diabetes: interactions with metformin. Diabetes 58:1604\u20131615. https:\/\/doi.org\/10.2337\/db09-0058","journal-title":"Diabetes"},{"key":"1890_CR9","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.2337\/db10-1740","volume":"60","author":"A Ait-Omar","year":"2011","unstructured":"Ait-Omar A, Monteiro-Sepulveda M, Poitou C et al (2011) GLUT2 accumulation in enterocyte apical and intracellular membranes: a study in morbidly obese human subjects and ob\/ob and high fat-fed mice. Diabetes 60:2598\u20132607. https:\/\/doi.org\/10.2337\/db10-1740","journal-title":"Diabetes"},{"key":"1890_CR10","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s13139-020-00647-6","volume":"54","author":"HS Chang","year":"2020","unstructured":"Chang HS, Kim SJ, Kim YH (2020) Association between colonic 18F-FDG uptake and glycemic control in patients with diabetes mellitus. Nucl Med Mol Imaging 54:168\u2013174. https:\/\/doi.org\/10.1007\/s13139-020-00647-6","journal-title":"Nucl Med Mol Imaging"},{"key":"1890_CR11","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1148\/radiol.2018180078","volume":"289","author":"R Hamidizadeh","year":"2018","unstructured":"Hamidizadeh R, Eftekhari A, Wiley EA et al (2018) Metformin discontinuation prior to FDG PET\/CT: a randomized controlled study to compare 24- and 48-hour bowel activity. Radiology 289:418\u2013425. https:\/\/doi.org\/10.1148\/radiol.2018180078","journal-title":"Radiology"},{"key":"1890_CR12","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1097\/00006231-200110000-00011","volume":"22","author":"HM Zhuang","year":"2001","unstructured":"Zhuang HM, Cortes-Blanco A, Pourdehnad M et al (2001) Do high glucose levels have differential effect on FDG uptake in inflammatory and malignant disorders? Nucl Med Commun 22:1123\u20131128. https:\/\/doi.org\/10.1097\/00006231-200110000-00011","journal-title":"Nucl Med Commun"},{"key":"1890_CR13","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00259-009-1330-7","volume":"37","author":"T Ozulker","year":"2010","unstructured":"Ozulker T, Ozulker F, Mert M et al (2010) Clearance of the high intestinal (18)F-FDG uptake associated with metformin after stopping the drug. Eur J Nucl Med Mol Imaging 37:1011\u20131117. https:\/\/doi.org\/10.1007\/s00259-009-1330-7","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1890_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00259-007-0563-6","volume":"35","author":"E Gontier","year":"2008","unstructured":"Gontier E, Fourme E, Wartski M et al (2008) High and typical 18F-FDG bowel uptake in patients treated with metformin. Eur J Nucl Med Mol Imaging 35:95\u201399. https:\/\/doi.org\/10.1007\/s00259-007-0563-6","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1890_CR15","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/dom.14262","volume":"23","author":"J Ito","year":"2021","unstructured":"Ito J, Nogami M, Morita Y et al (2021) Dose-dependent accumulation of glucose in the intestinal wall and lumen induced by metformin as revealed by 18 F-labelled fluorodeoxyglucose positron emission tomography-MRI. Diabetes Obes Metab 23:692\u2013699. https:\/\/doi.org\/10.1111\/dom.14262","journal-title":"Diabetes Obes Metab"},{"key":"1890_CR16","first-page":"301","volume":"61","author":"Y Sakar","year":"2010","unstructured":"Sakar Y, Meddah B, Faouzi MA et al (2010) Metformin-induced regulation of the intestinal d-glucose transporters. J Physiol Pharmacol 61:301\u2013307","journal-title":"J Physiol Pharmacol"},{"key":"1890_CR17","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2967\/jnumed.112.106666","volume":"54","author":"M Massollo","year":"2013","unstructured":"Massollo M, Marini C, Brignone M et al (2013) Metformin temporal and localized effects on gut glucose metabolism assessed using 18F-FDG PET in mice. J Nucl Med 54:259\u2013266. https:\/\/doi.org\/10.2967\/jnumed.112.106666","journal-title":"J Nucl Med"},{"key":"1890_CR18","doi-asserted-by":"publisher","first-page":"170104","DOI":"10.1098\/rob.170104","volume":"7","author":"X Sun","year":"2017","unstructured":"Sun X, Zhu MJ (2017) AMP-activated protein kinase: a therapeutic target in intestinal diseases. Open Biol 7:170104. https:\/\/doi.org\/10.1098\/rob.170104","journal-title":"Open Biol"},{"key":"1890_CR19","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2478\/enr-2018-0023","volume":"52","author":"T Nobashi","year":"2018","unstructured":"Nobashi T, Saga T, Nakamoto Y et al (2018) Enhanced intestinal 2-deoxy-2-[18F] fluoro-d-glucose uptake under metformin is not fully suppressed by loperamide. Endocr Regul 52:185\u2013191. https:\/\/doi.org\/10.2478\/enr-2018-0023","journal-title":"Endocr Regul"},{"key":"1890_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12902-016-0133-7","volume":"16","author":"Z Chen","year":"2016","unstructured":"Chen Z, Fu X, Huang J et al (2016) Single-dose acarbose decreased glucose-dependent insulinotropic peptide and glucagon levels in Chinese patients with newly diagnosed type 2 diabetes mellitus after a mixed meal. BMC Endocr Disord 16:55. https:\/\/doi.org\/10.1186\/s12902-016-0133-7","journal-title":"BMC Endocr Disord"},{"key":"1890_CR21","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00592-019-01385-8","volume":"57","author":"M Finessi","year":"2020","unstructured":"Finessi M, Bisi G, Deandreis D (2020) Hyperglycemia and 18F-FDG PET\/CT, issues and problem solving: a literature review. Acta Diabetol 57:253\u2013262. https:\/\/doi.org\/10.1007\/s00592-019-01385-8","journal-title":"Acta Diabetol"},{"key":"1890_CR22","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s00125-015-3844-9","volume":"59","author":"LJ McCreight","year":"2016","unstructured":"McCreight LJ, Bailey CJ, Pearson ER (2016) Metformin and the gastrointestinal tract. Diabetologia 59:426\u2013435. https:\/\/doi.org\/10.1007\/s00125-015-3844-9","journal-title":"Diabetologia"},{"key":"1890_CR23","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s12149-016-1106-7","volume":"30","author":"SH Lee","year":"2016","unstructured":"Lee SH, Jin S, Lee HS et al (2016) Metformin discontinuation less than 72 h is suboptimal for F-18 FDG PET\/CT interpretation of the bowel. Ann Nucl Med 30:629\u2013636. https:\/\/doi.org\/10.1007\/s12149-016-1106-7","journal-title":"Ann Nucl Med"},{"key":"1890_CR24","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s12149-020-01509-z","volume":"34","author":"N Schreuder","year":"2020","unstructured":"Schreuder N, Klarenbeek H, Vendel BN et al (2020) Discontinuation of metformin to prevent metformin-induced high colonic FDG uptake: \u0130s 48 h sufficient? Ann Nucl Med 34:833\u2013839. https:\/\/doi.org\/10.1007\/s12149-020-01509-z","journal-title":"Ann Nucl Med"},{"key":"1890_CR25","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.jacr.2018.09.006","volume":"16","author":"A Kaiser","year":"2019","unstructured":"Kaiser A, Davenport MS, Frey KA et al (2019) Management of diabetes mellitus before 18F-fluorodeoxyglucose PET\/CT: a nationwide patient-centered assessment of approaches to examination preparation. J Am Coll Radiol 16:804\u2013809. https:\/\/doi.org\/10.1016\/j.jacr.2018.09.006","journal-title":"J Am Coll Radiol"},{"key":"1890_CR26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2165\/11534750-000000000-00000","volume":"50","author":"GG Graham","year":"2011","unstructured":"Graham GG, Punt J, Arora M et al (2011) Clinical pharmacokinetics of metformin. Clin Pharmacokinet 50:81\u201398. https:\/\/doi.org\/10.2165\/11534750-000000000-00000","journal-title":"Clin Pharmacokinet"},{"key":"1890_CR27","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1046\/j.1365-2125.2000.00264.x","volume":"50","author":"PH Marathe","year":"2000","unstructured":"Marathe PH, Wen Y, Norton J et al (2000) Effect of altered gastric emptying and gastrointestinal motility on metformin absorption. Br J Clin Pharmacol 50:325\u2013332. https:\/\/doi.org\/10.1046\/j.1365-2125.2000.00264.x","journal-title":"Br J Clin Pharmacol"},{"key":"1890_CR28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3109\/00498259409043220","volume":"24","author":"C Wilcock","year":"1994","unstructured":"Wilcock C, Bailey CJ (1994) Accumulation of metformin by tissues of the normal and diabetic mouse. Xenobiotica 24:49\u201357. https:\/\/doi.org\/10.3109\/00498259409043220","journal-title":"Xenobiotica"},{"key":"1890_CR29","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1007\/s00125-008-1053-5","volume":"51","author":"CJ Bailey","year":"2008","unstructured":"Bailey CJ, Wilcock C, Scarpello JH (2008) Metformin and the intestine. Diabetologia 51:1552\u20131553. https:\/\/doi.org\/10.1007\/s00125-008-1053-5","journal-title":"Diabetologia"},{"key":"1890_CR30","first-page":"145","volume":"33","author":"MM Abouzied","year":"2005","unstructured":"Abouzied MM, Crawford ES, Nabi HA (2005) 18F-FDG imaging: pitfalls and artifacts. J Nucl Med Technol 33:145\u2013155","journal-title":"J Nucl Med Technol"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-022-01890-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-022-01890-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-022-01890-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T04:27:20Z","timestamp":1654057640000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00592-022-01890-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,16]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["1890"],"URL":"https:\/\/doi.org\/10.1007\/s00592-022-01890-3","relation":{},"ISSN":["1432-5233"],"issn-type":[{"type":"electronic","value":"1432-5233"}],"subject":[],"published":{"date-parts":[[2022,4,16]]},"assertion":[{"value":"3 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by the Ethics Committee of Erciyes University Medical School.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all the diabetic and non-diabetic patients who were candidate for the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}